Combined p14ARF and antisense EGFR potentiate the efficacy of adenovirus-mediated gene therapy in laryngeal squamous cell carcinoma (LSCC). (Q40165500)
Jump to navigation
Jump to search
scientific article published on February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined p14ARF and antisense EGFR potentiate the efficacy of adenovirus-mediated gene therapy in laryngeal squamous cell carcinoma (LSCC). |
scientific article published on February 2007 |
Statements
1 reference
Combined p14ARF and antisense EGFR potentiate the efficacy of adenovirus-mediated gene therapy in laryngeal squamous cell carcinoma (LSCC). (English)
1 reference
Junming Xian
1 reference
Yinghe Lin
1 reference
Yafeng Liu
1 reference
Ping Gong
1 reference
Shixi Liu
1 reference
1 February 2007
1 reference
1 reference
26
1 reference
2
1 reference
71-79
1 reference
Identifiers
1 reference
1 reference